These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


508 related items for PubMed ID: 11833860

  • 1. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb 01; 25(1):42-9. PubMed ID: 11833860
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
    Xyrem International Study Group.
    J Clin Sleep Med; 2005 Oct 15; 1(4):391-7. PubMed ID: 17564408
    [Abstract] [Full Text] [Related]

  • 3. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy.
    Sleep; 2003 Feb 01; 26(1):31-5. PubMed ID: 12627729
    [Abstract] [Full Text] [Related]

  • 4. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun 01; 16(89):98-101. PubMed ID: 17582923
    [Abstract] [Full Text] [Related]

  • 5. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
    Xyrem International Study Group.
    Sleep Med; 2005 Sep 01; 6(5):415-21. PubMed ID: 16099718
    [Abstract] [Full Text] [Related]

  • 6. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J, Pardi D, Hornfeldt CS, Inhaber N.
    Sleep Med; 2009 Sep 01; 10(8):829-35. PubMed ID: 19616998
    [Abstract] [Full Text] [Related]

  • 7. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
    Mansukhani MP, Kotagal S.
    Sleep Med; 2012 Jun 01; 13(6):606-10. PubMed ID: 22445591
    [Abstract] [Full Text] [Related]

  • 8. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy.
    U.S. Xyrem Multicenter Study Group.
    Sleep Med; 2004 Mar 01; 5(2):119-23. PubMed ID: 15033130
    [Abstract] [Full Text] [Related]

  • 9. Sodium oxybate for cataplexy.
    Lemon MD, Strain JD, Farver DK.
    Ann Pharmacother; 2006 Mar 01; 40(3):433-40; quiz 581-2. PubMed ID: 16507620
    [Abstract] [Full Text] [Related]

  • 10. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Russell IJ, Perkins AT, Michalek JE, Oxybate SXB-26 Fibromyalgia Syndrome Study Group.
    Arthritis Rheum; 2009 Jan 01; 60(1):299-309. PubMed ID: 19116896
    [Abstract] [Full Text] [Related]

  • 11. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study.
    Ondo WG, Perkins T, Swick T, Hull KL, Jimenez JE, Garris TS, Pardi D.
    Arch Neurol; 2008 Oct 01; 65(10):1337-40. PubMed ID: 18852348
    [Abstract] [Full Text] [Related]

  • 12. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.
    Plazzi G, Ruoff C, Lecendreux M, Dauvilliers Y, Rosen CL, Black J, Parvataneni R, Guinta D, Wang YG, Mignot E.
    Lancet Child Adolesc Health; 2018 Jul 01; 2(7):483-494. PubMed ID: 30169321
    [Abstract] [Full Text] [Related]

  • 13. A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy.
    Weaver TE, Cuellar N.
    Sleep; 2006 Sep 01; 29(9):1189-94. PubMed ID: 17040006
    [Abstract] [Full Text] [Related]

  • 14. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
    Poza-Aldea JJ.
    Rev Neurol; 2006 Sep 01; 48(1):27-31. PubMed ID: 19145563
    [Abstract] [Full Text] [Related]

  • 15. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia.
    Scharf MB, Baumann M, Berkowitz DV.
    J Rheumatol; 2003 May 01; 30(5):1070-4. PubMed ID: 12734908
    [Abstract] [Full Text] [Related]

  • 16. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T, White D, Schmidt-Nowara W, Wesnes KA, Niebler G, Arora S, Black J.
    Clin Ther; 2006 May 01; 28(5):689-706. PubMed ID: 16861091
    [Abstract] [Full Text] [Related]

  • 17. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
    Huang YS, Guilleminault C.
    Pediatr Neurol; 2009 Jul 01; 41(1):9-16. PubMed ID: 19520267
    [Abstract] [Full Text] [Related]

  • 18. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
    Harsh JR, Hayduk R, Rosenberg R, Wesnes KA, Walsh JK, Arora S, Niebler GE, Roth T.
    Curr Med Res Opin; 2006 Apr 01; 22(4):761-74. PubMed ID: 16684437
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 01; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 20. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J, Houghton WC.
    Sleep; 2006 Jul 01; 29(7):939-46. PubMed ID: 16895262
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.